CPHI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Login
View profile
Log out
Welcome back

Click below to sign in and see leads, RFIs or statistics

Sign in

Sign out
- Search Impressions
  
  3 287
- Page views
  
  324
- Request for information
  
  54
Subscribe

Loratan Pro (loratadine 10 mg)

Loratan Pro (loratadine 10 mg)

Product Description

Type: Medicines
Pharmaceutical form: Capsules
Package: 10 capsules

Active principle:
One capsule contains 10mg of Loratadine (Loratadinum)

Indications:
Symptomatic treatment of allergic rhinitis and chronic idiopathic urticaria.

Contraindications:
Hypersensitivity to the active substance (Loratadine) or to any of the excipients. Do not use Loratan pro during pregnancy.
brhrbrloratadine 10 mg

Hasco-Lek S.A.

Hasco-Lek S.A.

Country/Region:

Poland
On CPHI since:

2015
Certificates:

2
Employees:

500 - 999

Company types

Generics/Biosimilars Manufacturer

Licensee

Pharmaceutical company

Primary activities

Pharmaceutical Company (generic finished products)

Compare Add to favorites Added to favorites

Specifications

Selling Points
Brand Name
Model

soft gelatin capsule
Supplied from

Poland
Measured In
piece

Sales Markets

Europe - EU countries
Europe - non EU (e.g. UK, Russia, ex-CIS countries)

Hasco-Lek S.A.

Hasco-Lek S.A.

Country/Region:

Poland
On CPHI since:

2015
Certificates:

2
Employees:

500 - 999

Company types

Generics/Biosimilars Manufacturer

Licensee

Pharmaceutical company

Primary activities

Pharmaceutical Company (generic finished products)

Compare Add to favorites Added to favorites